Protective effects of recombinant human bone morphogenetic protein-7 on focal cerebral ischemia-reperfusion injury

International Journal of Neuroscience

Volumn 123, Issue 6, 2013, Pages 375-384

  Xu, Ji Hong ^a   Zhang, Tie Zheng ^a   Zhao, Yan Yan ^b   Wang, Jun Ke ^b   Yuan, Zhi Guo ^b  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Bone morphogenetic proteins; NF B; Reperfusion injury

Indexed keywords

BIOTIN; DNA NUCLEOTIDYLEXOTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RECOMBINANT OSTEOGENIC PROTEIN 1; SYNAPTOTAGMIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN EDEMA; BRAIN FUNCTION; BRAIN ISCHEMIA; BRAIN TISSUE; BRAIN WATER; COMPARATIVE STUDY; DRUG EFFECT; FEMORAL VEIN; IMMUNOHISTOCHEMISTRY; INJECTION; LEFT HEMISPHERE; MIDDLE CEREBRAL ARTERY OCCLUSION; MITOCHONDRIAL MEMBRANE; MORPHOLOGICAL TRAIT; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION; REPERFUSION INJURY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BONE MORPHOGENETIC PROTEIN 7; BRAIN; BRAIN EDEMA; BRAIN ISCHEMIA; HUMANS; NERVOUS SYSTEM DISEASES; NF-KAPPA B; RATS; RECOMBINANT PROTEINS; REPERFUSION INJURY; WATER;

EID: 84878049054     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2012.761614     Document Type: Article

References (36)

1. Berti R, Williams AJ, Moffett JR, et al. Quantitative real-timeRT-PCR analysis of inflammatory gene expression associatedwith ischemia-reperfusion brain injury. J Cereb Blood FlowMetab 2002;22:1068-79.
2. Huang Q, Tatro JB. Alpha-melanocyte stimulating hormonesuppresses intracerebral tumor necrosis factor-alpha andinterleukin-1beta gene expression following transient cerebralischemia in mice. Neurosci Lett 2002;334:186-90.
3. Clemens JA, Stephenson DT, Yin T, et al. Drug-induced neuroprotectionfrom global ischemia is associated with preventionof persistent but not transient activation of nuclear factor-kappaB in rats. Stroke 1998;29:677-82.
4. Urist MR, Mikulski A, Conteas CN. Reversible extinction ofthe morphogen in bone matrix by reduction and oxidation ofdisulfide bonds. Calcif Tissue Res 1975;19:73-83.
5. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins.Growth Factors 2004;22:233-41.
6. Ducy P, Karsenty G. The family of bone morphogenetic proteins.Kidney Int 2000;57:2207-14.
7. Wozney JM. Overview of bone morphogenetic proteins. Spine(Phila Pa 1976) 2002;27:S2-8.
8. Harvey BK, Hoffer BJ,Wang Y. Stroke and TGF-beta proteins:glial cell line-derived neurotrophic factor and bone morphogeneticprotein. Pharmacol Ther 2005;105:113-259.
9. Chang CF, Morales M, Chou J, et al. Bone morphogeneticproteins are involved in fetal kidney tissue transplantationinducedneuroprotection in stroke rats. Neuropharmacol2002;43:418-26.
10. Charytoniuk DA, Traiffort E, Pinard E, et al. Distributionof bone morphogenetic protein and bone morphogenetic proteinreceptor transcripts in the rodent nervous system and upregulationof bone morphogenetic protein receptor type II inhippocampal dentate gyrus in a rat model of global cerebral ischemia.Neuroscience 2000;100:33-43.
11. Chang CF, Lin SZ, Chiang YH, et al. Intravenous administrationof bone morphogenetic protein-7 after ischemia improvesmotor function in stroke rats. Stroke 2003;34:558-64.
12. Chou J, Harvey BK, Chang CF, et al. Neuroregenerative effectsof BMP7 after stroke in rats. J Neurol Sci 2006;240:21-9.
13. SimonM,Maresh JG, Harris SE, et al. Expression of bone morphogeneticprotein-7 mRNA in normal and ischemic adult ratkidney. Am J Physiol 1999;276:F382-9.
14. Lin SZ, Hoffer BJ, Kaplan P, Wang Y. Osteogenic protein-1protects against cerebral infarction induced by MCA ligation inadult rats. Stroke 1999;30:126-33.
15. Xu JH, Zhao YY, Wang JK, et al. Effects of mouse recombinantbone morphogenetic protein-7 transfection on cell apoptosis,NF-kappa B, and downstream genes in cultured primarycardiomyocytes after simulated ischemia and reperfusion injury.J Cardiovasc Pharmacol 2010;56:69-77.
16. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversiblemiddle cerebral artery occlusion without craniectomy in rats.Stroke 1989;20:84-91.
17. AlmanzarMM,FrazierKS, Dube PH, et al.Osteogenic protein-1 mRNA expression is selectively modulated after acute ischemicrenal injury. J Am Soc Nephrol 1998;9:1456-63.
18. Zhen-Qiang F, Bing-Wei Y, Yong-Liang L, et al. Localized expressionof human BMP-7 by BM-MSCs enhances renal repairin an in vivo model of ischemia-reperfusion injury. Genes Cells2012;17:53-64.
19. Nakazawa J, Isshiki K, Sugimoto T, et al. Renoprotective effectsof asialoerythropoietin in diabetic mice against ischaemiareperfusion-induced acute kidney injury. Nephrology (Carlton)2010;15:93-101.
20. Shen H, Luo Y, Kuo CC, Wang Y. BMP7 reduces synergisticinjury induced by methamphetamine and ischemia in mousebrain. Neurosci Lett 2008;442:15-8.
21. Radhakrishnan RS, Radhakrishnan GL, Radhakrishnan HR,et al. Pretreatment with bone morphogenetic protein-7 (BMP-7) mimics ischemia preconditioning following intestinal ischemia/reperfusion injury in the intestine and liver. Shock2008;30:532-6.
22. Lefer AM, Tsao PS,Ma XL, Sampath TK. Anti-ischaemic andendothelial protective actions of recombinant human osteogenicprotein (hOP-1). J Mol Cell Cardiol 1992;24:585-93.
23. Vukicevic S, Basic V, Rogic D, et al. Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J Clin Invest 1998;102:202-14.
24. Jordan J, Bottner M, Schluesener HJ, et al. Bone morphogeneticproteins: neurotrophic roles for midbrain dopaminergicneurons and implications of astroglial cells. Eur J Neurosci1997;9:1699-709.
25. Mehler MF, Mabie PC, Zhang D, Kessler JA. Bone morphogeneticproteins in the nervous system. Trends Neurosci1997;20:309-17.
26. Marumo T, Hishikawa K, Yoshikawa M, Fujita T. Epigeneticregulation of BMP7 in the regenerative response to ischemia. JAm Soc Nephrol 2008 Jul;19(7):1311-20.
27. Liu Y, Belayev L, Zhao W, et al. The effect of bone morphogeneticprotein- 7 (BMP-7) on functional recovery, local cerebralglucose utilization and blood flow after transient focal cerebralischemia in rats. Brain Res 2001;905:81-90.
28. Esquenazi S, Monnerie H, Kaplan P, et al. BMP-7 and excessglutamate: opposing effects on dendrite growth from cerebralcortical neurons in vitro. Exp Neurol. 2002;176(1):41-54.
29. Lee MJ, Yang CW, Jin DC, et al. Bone morphogenetic protein-7 inhibits constitutive and interleukin-1 beta-induced monocytechemoattractant protein-1 expression in human mesangial cells:role for JNK/AP-1 pathway. J Immunol 2003;170:2557-63.
30. Gould SE, Day M, Jones SS, Dorai H. BMP-7 regulateschemokine, cytokine, and hemodynamic gene expression inproximal tubule cells. Kidney Int 2002;61:51-60.
31. Shen H, Luo Y, Kuo CC, Wang Y. BMP7 reduces synergisticinjury induced by methamphetamine and ischemia in mousebrain. Neurosci Lett 2008;442:15-8.
32. Cox S, Harvey BK, Sanchez JF, et al. Mediation of BMP7 neuroprotectionby MAPK and PKC IN rat primary cortical cultures.Brain Res 2004;1010:55-61.
33. Schneider A, Martin-Villalba A, Weih F, et al. NF-kappa B isactivated and promotes cell death in focal cerebral ischemia.NatMed. 1999;5:554-9.
34. Clemens JA, Stephenson DT, Dixon EP, et al. Global cerebralischemia activates nuclear factor-kappa B prior to evidenceof DNA fragmentation. Brain Res Mol Brain Res 1997;48:187-96.
35. Carroll JE, Howard EF, Hess DC, et al. Nuclear factor-kappaB activation during cerebral reperfusion: effect of attenuationwith N-acetylcysteine treatment. Brain Res Mol Brain Res1998;56:186-91.
36. Botchkina GI, Geimonen E, Bilof ML, et al. Loss of NF-kappaB activity during cerebral ischemia and TNF cytotoxicity. MolMed 1999;5:372-81.